Rhumbline Advisers »

Caris Life Sciences shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $650k 22k 30.25

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Alphabet Inc Class C cs (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
MasterCard Incorporated (MA)

View all positions for Rhumbline Advisers

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences